The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...

Inhalers generally expire 1 year after they’re issued, but depending on how they’re stored, they may be good for months after that. If there’s any doubt, get a new one. You may wonder ...

A pimple-like bump or sore inside the nose can sometimes be due to nasal vestibulitis or nasal folliculitis. It is a bacterial infection that can develop when hair follicles become infected ...

Inhalers for COPD provide steroids, bronchodilators, or combination drugs. The three types differ in the mechanism by which the medication is inhaled and have different instructions for use. If ...

Taiwan’s Air Force said the officer was “inhaled by the engine for unknown reasons.” She later was pronounced dead after life-saving efforts were unsuccessful. “In response to media ...

MILLIONS of Brits with asthma are potentially risking their lives by not using their inhaler properly, UK experts have warned The UK has one worst death rates from the lung condition in Europe ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

He didn’t have his inhaler at the time. The family said he had to forgo his inhaler because of the dramatically increased price of his prescription. At the center of the case are prescription ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...